<DOC>
	<DOC>NCT00626002</DOC>
	<brief_summary>The purpose of this study is to evaluate long term safety, efficacy and tolerability of ABT-874 in adults with moderate to severe psoriasis.</brief_summary>
	<brief_title>Open Label Continuation Study in Moderate to Severe Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Having participated in a preceding ABT874 clinical trial for ABT874 Subject has a clinical diagnosis of moderate to severe plaque psoriasis Subjects who prematurely discontinued in any preceding psoriasis study with ABT874 other than protocolrequired discontinuation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Open label</keyword>
</DOC>